These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25529272)

  • 21. Nicotinic receptors, allosteric proteins and medicine.
    Changeux JP; Taly A
    Trends Mol Med; 2008 Mar; 14(3):93-102. PubMed ID: 18262468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for allosteric transitions of a multidomain pentameric ligand-gated ion channel.
    Hu H; Howard RJ; Bastolla U; Lindahl E; Delarue M
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13437-13446. PubMed ID: 32482881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
    Brejc K; van Dijk WJ; Klaassen RV; Schuurmans M; van Der Oost J; Smit AB; Sixma TK
    Nature; 2001 May; 411(6835):269-76. PubMed ID: 11357122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nicotinic receptor ligand binding domain.
    Sine SM
    J Neurobiol; 2002 Dec; 53(4):431-46. PubMed ID: 12436411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elucidating ligand binding and channel gating mechanisms in pentameric ligand-gated ion channels by atomistic simulations.
    Comitani F; Melis C; Molteni C
    Biochem Soc Trans; 2015 Apr; 43(2):151-6. PubMed ID: 25849909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unravelling the conformational plasticity of the extracellular domain of a prokaryotic nAChR homologue in solution by NMR.
    Chasapis CT; Argyriou AI; Corringer PJ; Bentrop D; Spyroulias GA
    Biochemistry; 2011 Nov; 50(45):9681-3. PubMed ID: 22007668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-ray structure of the human α4β2 nicotinic receptor.
    Morales-Perez CL; Noviello CM; Hibbs RE
    Nature; 2016 Oct; 538(7625):411-415. PubMed ID: 27698419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist activation of a nicotinic acetylcholine receptor.
    Auerbach A
    Neuropharmacology; 2015 Sep; 96(Pt B):150-6. PubMed ID: 25446670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the prokaryotic pentameric ligand-gated ion channel ELIC by divalent cations.
    Zimmermann I; Marabelli A; Bertozzi C; Sivilotti LG; Dutzler R
    PLoS Biol; 2012; 10(11):e1001429. PubMed ID: 23185134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotinic receptors at the amino acid level.
    Corringer PJ; Le Novère N; Changeux JP
    Annu Rev Pharmacol Toxicol; 2000; 40():431-58. PubMed ID: 10836143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor.
    Brejc K; van Dijk WJ; Smit AB; Sixma TK
    Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
    Tsetlin V; Utkin Y; Kasheverov I
    Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phylogenetic conservation of protein-lipid motifs in pentameric ligand-gated ion channels.
    Barrantes FJ
    Biochim Biophys Acta; 2015 Sep; 1848(9):1796-805. PubMed ID: 25839355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy.
    Iturriaga-Vásquez P; Alzate-Morales J; Bermudez I; Varas R; Reyes-Parada M
    Pharmacol Res; 2015 Nov; 101():9-17. PubMed ID: 26318763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the Cys Loop and Transmembrane Domain in the Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors.
    Alcaino C; Musgaard M; Minguez T; Mazzaferro S; Faundez M; Iturriaga-Vasquez P; Biggin PC; Bermudez I
    J Biol Chem; 2017 Jan; 292(2):551-562. PubMed ID: 27864368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of acetylcholine binding site residues contributing to nicotinic acetylcholine receptor gating: role of residues Y93, Y190, K145 and D200.
    Mallipeddi PL; Pedersen SE; Briggs JM
    J Mol Graph Model; 2013 Jul; 44():145-54. PubMed ID: 23831994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural organization of nicotinic acetylcholine receptors.
    Utkin YuN ; Tsetlin VI; Hucho F
    Membr Cell Biol; 2000; 13(2):143-64. PubMed ID: 10779169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotinic receptor pharmacology in silico: Insights and challenges.
    Gulsevin A
    Neuropharmacology; 2020 Oct; 177():108257. PubMed ID: 32738311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.
    Olsen RW
    Adv Pharmacol; 2015; 73():167-202. PubMed ID: 25637441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversity of native nicotinic receptor subtypes in mammalian brain.
    Zoli M; Pistillo F; Gotti C
    Neuropharmacology; 2015 Sep; 96(Pt B):302-11. PubMed ID: 25460185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.